Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pseudomyxoma Peritonei × Alemtuzumab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 37 Leukemia 29 Lymphoma 20 Hodgkin Disease 14 Myelodysplastic Syndromes 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Multiple Myeloma 8 Lymphoma, Non-Hodgkin 8 Lymphoma, Mantle-Cell 8 Recurrence 7 Myeloproliferative Disorders 7 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma, Follicular 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myeloid, Acute 7 Anemia, Aplastic 7 Lymphoma, B-Cell, Marginal Zone 6 Sezary Syndrome 5 Primary Myelofibrosis 5 Mycosis Fungoides 5 Lymphoma, T-Cell, Peripheral 5 Congenital Abnormalities 5 Burkitt Lymphoma 5 Waldenstrom Macroglobulinemia 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Large-Cell, Immunoblastic 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia, Large Granular Lymphocytic 4 Graft vs Host Disease 4

Interventions

Mitomycin 2 Capecitabine 2 Tacrolimus 1 Specimen Handling 1 Sirolimus 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Lansoprazole 1 Ipilimumab 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cytoreduction Surgical Procedures 1 Clarithromycin 1 CTLA-4 Antigen 1 Bromelains 1 Amoxicillin 1 Alemtuzumab 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06084780 2026-01-23

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡